{
    "eid": "2-s2.0-85049583944",
    "title": "A simplified scoring system in de novo follicular lymphoma treated initially with immunochemotherapy",
    "cover-date": "2018-07-05",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Biochemistry",
            "@code": "1303",
            "@abbrev": "BIOC"
        },
        {
            "@_fa": "true",
            "$": "Immunology",
            "@code": "2403",
            "@abbrev": "IMMU"
        },
        {
            "@_fa": "true",
            "$": "Hematology",
            "@code": "2720",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Cell Biology",
            "@code": "1307",
            "@abbrev": "BIOC"
        }
    ],
    "keywords": [],
    "authors": [
        "Emmanuel Bachy",
        "Matthew J. Maurer",
        "Thomas M. Habermann",
        "B\u00e9n\u00e9dicte Gelas-Dore",
        "Delphine Maucort-Boulch",
        "Jane A. Estell",
        "Eric Van den Neste",
        "R\u00e9da Bouabdallah",
        "Emmanuel Gyan",
        "Andrew L. Feldman",
        "Joan Bargay",
        "Alain Delmer",
        "Susan L. Slager",
        "Maria Gomes da Silva",
        "Olivier Fitoussi",
        "David Belada",
        "Herv\u00e9 Maisonneuve",
        "Tanin Intragumtornchai",
        "Stephen M. Ansell",
        "Thierry Lamy",
        "Peggy Dartigues",
        "Brian K. Link",
        "John F. Seymour",
        "James R. Cerhan",
        "Gilles Salles"
    ],
    "citedby-count": 118,
    "ref-count": 41,
    "ref-list": [
        "US lymphoid malignancy statistics by World Health Organization subtypes",
        "Rates and outcomes of follicular lymphoma transformation in the immunochemotherapy era: A report from the University of Iowa/ MayoClinic Specialized Program of Research Excellence Molecular Epidemiology Resource",
        "Comparison in low-tumor-burden follicular lymphomas between an initial no-treatment policy, prednimustine, or interferon alfa: A randomized study from the Groupe d\u2019Etude des Lymphomes Folliculaires. Groupe d\u2019Etude des Lymphomes de l\u2019Adulte",
        "Rituximab added to first-line mitoxantrone, chlorambucil, and prednisolone chemotherapy followed by interferon maintenance prolongs survival in patients with advanced follicular lymphoma: An East German Study Group Hematology and Oncology Study",
        "Frontline therapy with rituximab added to the combination of cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) significantly improves the outcome for patients with advanced-stage follicular lymphoma compared with therapy with CHOP alone: Results of a prospective randomized study of the German Low-Grade Lymphoma Study Group",
        "CVP chemotherapy plus rituximab compared with CVP as first-line treatment for advanced follicular lymphoma",
        "Phase III study of R-CVP compared with cyclophosphamide, vincristine, and prednisone alone in patients with previously untreated advanced follicular lymphoma",
        "Rituximab combined with chemotherapy and interferon in follicular lymphoma patients: Results of the GELA-GOELAMS FL2000 study",
        "Maintenance rituximab after cyclophosphamide, vincristine, and prednisone prolongs progression-free survival in advanced indolent lymphoma: Results of the randomized phase III ECOG1496 Study",
        "Bendamustine plus rituximab is effective and has a favorable toxicity profile in the treatment of mantle cell and low-grade non-Hodgkin\u2019s lymphoma",
        "Bendamustine plus rituximab versus CHOP plus rituximab as first-line treatment for patients with indolent and mantle-cell lymphomas: An open-label, multicentre, randomised, phase 3 non-inferiority trial",
        "What is the best first-line treatment strategy for patients with indolent lymphomas?",
        "Obinutuzumab for the first-line treatment of follicular lymphoma",
        "Prognosis of follicular lymphoma: A predictive model based on a retrospective analysis of 987 cases. Intergruppo Italiano Linfomi",
        "Follicular lymphoma international prognostic index",
        "Follicular lymphoma international prognostic index 2: A new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project",
        "A comparative analysis of prognostic factor models for follicular lymphoma based on a phase III trial of CHOP-rituximab versus CHOP 1 131iodine\u2013tositumomab",
        "Integration of gene mutations in risk prognostication for patients receiving first-line immunochemotherapy for follicular lymphoma: A retrospective analysis of a prospective clinical trial and validation in a population-based registry",
        "Clinico-biological features, treatment and survival of 457 patients with histological Grades 3A and 1-2 follicular lymphoma mostly treated with immunochemotherapy",
        "Validation of follicular lymphoma international prognostic index 2 (FLIPI2) score in an independent series of follicular lymphoma patients",
        "Rituximab maintenance for 2 years in patients with high tumour burden follicular lymphoma responding to rituximab plus chemotherapy (PRIMA): A phase 3, randomised controlled trial",
        "Cohort Profile: The Lymphoma Specialized Program of Research Excellence (SPORE) Molecular Epidemiology Resource (MER) Cohort Study",
        "Early relapse of follicular lymphoma after rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone defines patients at high risk for death: An analysis from the National LymphoCare Study",
        "Early event status informs subsequent outcome in newly diagnosed follicular lymphoma",
        "Modeling Survival Data: Extending the Cox Model",
        "Extending the elements of tree-structured regression",
        "Partykit: A modular toolkit for recursive partytioning in R",
        "A systematic selection method for the development of cancer staging systems",
        "Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers",
        "A predictive model for aggressive non-Hodgkin\u2019s lymphoma",
        "Applicability of the International Index for aggressive lymphomas to patients with low-grade lymphoma",
        "Prognostic relevance of serum beta2 microglobulin in patients with follicular lymphoma treated with anthracycline-containing regimens. A GISL study",
        "Survival after progression in patients with follicular lymphoma: Analysis of prognostic factors",
        "Prognostic value of serum beta-2 microglobulin in low-grade lymphoma",
        "International staging system for multiple myeloma",
        "Baseline metabolic tumor volume predicts outcome in high-tumor-burden follicular lymphoma: A pooled analysis of three multicenter studies",
        "Positron emission tomography-computed tomography (PET-CT) after induction therapy is highly predictive of patient outcome in follicular lymphoma: Analysis of PET-CT in a subset of PRIMA trial participants",
        "The value of PET/CT in detecting bone marrow involvement in patients with follicular lymphoma",
        "Long-term follow-up of patients with newly diagnosed follicular lymphoma in the prerituximab era: Effect of response quality on survival\u2013A study from the groupe d\u2019etude des lym-phomes de l\u2019adulte",
        "Thirty-month complete response as a surrogate end point in first-line follicular lymphoma therapy: An individual patient-level analysis of multiple randomized trials"
    ],
    "affiliation": [
        {
            "affiliation-city": "Rochester",
            "@id": "60005558",
            "affilname": "Mayo Clinic",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60005558",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Sydney",
            "@id": "60121699",
            "affilname": "The University of Sydney School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60121699",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Villeurbanne",
            "@id": "60101362",
            "affilname": "Laboratoire de Biom\u00e9trie et Biologie \u00c9volutive",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60101362",
            "affiliation-country": "France"
        },
        {
            "affiliation-city": "Palma",
            "@id": "60068628",
            "affilname": "Hospital Universitari Son Ll\u00e0tzer",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60068628",
            "affiliation-country": "Spain"
        },
        {
            "affiliation-city": "Sydney",
            "@id": "60029482",
            "affilname": "Concord Repatriation General Hospital",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60029482",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Marseille",
            "@id": "60028690",
            "affilname": "Institut Paoli-Calmettes",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028690",
            "affiliation-country": "France"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Villejuif",
            "@id": "60027386",
            "affilname": "Institut de Cancerologie Gustave Roussy",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60027386",
            "affiliation-country": "France"
        },
        {
            "affiliation-city": "Rennes",
            "@id": "60026968",
            "affilname": "H\u00f4pital Pontchaillou",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026968",
            "affiliation-country": "France"
        },
        {
            "affiliation-city": "Melbourne",
            "@id": "60026553",
            "affilname": "University of Melbourne",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60026553",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Lisbon",
            "@id": "60023634",
            "affilname": "Instituto Portugues de Oncologia de Francisco Gentil Lisboa",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60023634",
            "affiliation-country": "Portugal"
        },
        {
            "affiliation-city": "Villeurbanne",
            "@id": "60023578",
            "affilname": "Universit\u00e9 Claude Bernard Lyon 1",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60023578",
            "affiliation-country": "France"
        },
        {
            "affiliation-city": "Reims",
            "@id": "60019394",
            "affilname": "Universit\u00e9 de Reims Champagne-Ardenne",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60019394",
            "affiliation-country": "France"
        },
        {
            "affiliation-city": "Hradec Kralove",
            "@id": "60018451",
            "affilname": "Fakultn\u00ed Nemocnice Hradec Kr\u00e1lov\u00e9",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018451",
            "affiliation-country": "Czech Republic"
        },
        {
            "affiliation-city": "Tours",
            "@id": "60016638",
            "affilname": "Centre Hospitalier Regional et Universitaire de Tours",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016638",
            "affiliation-country": "France"
        },
        {
            "affiliation-city": "Prague",
            "@id": "60016605",
            "affilname": "Charles University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016605",
            "affiliation-country": "Czech Republic"
        },
        {
            "affiliation-city": "Brussels",
            "@id": "60012936",
            "affilname": "Cliniques Universitaires Saint-Luc",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012936",
            "affiliation-country": "Belgium"
        },
        {
            "affiliation-city": "Lyon",
            "@id": "60012357",
            "affilname": "CHU de Lyon",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60012357",
            "affiliation-country": "France"
        },
        {
            "affiliation-city": "Iowa City",
            "@id": "60009788",
            "affilname": "University of Iowa Carver College of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60009788",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Roche sur Yon",
            "@id": "127107381",
            "affilname": "Centre Hospitalier de la Roche sur Yon",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/127107381",
            "affiliation-country": "France"
        },
        {
            "affiliation-city": "Lyon",
            "@id": "125842216",
            "affilname": "LYSARC",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/125842216",
            "affiliation-country": "France"
        },
        {
            "affiliation-city": "Bordeaux",
            "@id": "100380131",
            "affilname": "Polyclinique Bordeaux Nord Aquitaine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/100380131",
            "affiliation-country": "France"
        }
    ],
    "funding": [
        "European Union\u2019s Horizon 2020 research and innovation program",
        "Marie Sklodowska-Curie",
        "Monahan Foundation",
        "National Institutes of Health",
        "National Cancer Institute",
        "Philippe Foundation"
    ]
}